Curative Biotechnology Inc (CUBT) — Financial Flexibility Index
Curative Biotechnology Inc (CUBT) has a Financial Flexibility Index of -0.02x as of March 2026. Free cash flow of $-193.12K (operating CF $-193.12K minus capex $0.00) represents 0% of total liabilities ($8.37 Million). Check Curative Biotechnology Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Curative Biotechnology Inc Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Curative Biotechnology Inc across 13 annual periods. For the full cash flow conversion analysis, see Curative Biotechnology Inc cash conversion from operations.
Annual Financial Flexibility Index for Curative Biotechnology Inc (2013–2025)
Year-by-year free cash flow to debt coverage for Curative Biotechnology Inc. Explore CUBT cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.11x | $-868.86K | $-868.87K | $8.20 Million | ▲ +26.7% |
| 2024 | -0.14x | $-1.02 Million | $-1.02 Million | $7.08 Million | ▼ -75.7% |
| 2023 | -0.08x | $-472.54K | $-486.58K | $5.75 Million | ▼ -27.5% |
| 2022 | -0.06x | $-1.46 Million | $-1.54 Million | $22.62 Million | ▲ +23.5% |
| 2021 | -0.08x | $-1.58 Million | $-1.60 Million | $18.77 Million | ▼ -267.7% |
| 2020 | -0.02x | $-155.79K | $-190.09K | $6.80 Million | ▼ -236.2% |
| 2019 | 0.02x | $6.68K | $-150.00 | $397.10K | ▲ +8340.4% |
| 2018 | 0.00x | $-150.00 | $-150.00 | $734.36K | ▲ +2.2% |
| 2017 | 0.00x | $-150.00 | $-150.00 | $718.33K | ▲ +97.5% |
| 2016 | -0.01x | $-5.89K | $-5.89K | $702.29K | ▼ -394.8% |
| 2015 | 0.00x | $1.96K | $1.96K | $687.16K | ▲ +119.3% |
| 2014 | -0.01x | $-14.16K | $-20.99K | $960.99K | ▼ -291.1% |
| 2013 | 0.01x | $7.19K | $-35.68K | $932.66K | — |